|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wu HH, Lin WC and Tsai KW: Advances in
molecular biomarkers for gastric cancer: miRNAs as emerging novel
cancer markers. Expert Rev Mol Med. 16:e12014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dassen AE, Lemmens VE, van de Poll-Franse
LV, Creemers GJ, Brenninkmeijer SJ, Lips DJ, Wurff Vd AA, Bosscha K
and Coebergh JW: Trends in incidence, treatment and survival of
gastric adenocarcinoma between 1990 and 2007: A population-based
study in the Netherlands. Eur J Cancer. 46:1101–1110. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang H, Wang L, Tang X and Bai W: miR-203a
suppresses cell proliferation by targeting E2F transcription factor
3 in human gastric cancer. Oncol Lett. 14:7687–7690.
2017.PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wienholds E and Plasterk RH: MicroRNA
function in animal development. FEBS Lett. 579:5911–5922. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Agrawal L, Sahu S, Ghosh S, Shiga T,
Fujita D and Bandyopadhyay A: Inventing atomic resolution scanning
dielectric microscopy to see a single protein complex operation
live at resonance in a neuron without touching or adulterating the
cell. J Integr Neurosci. 15:435–462. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang S, Ge W, Zou G, Yu L, Zhu Y, Li Q,
Zhang Y, Wang Z and Xu T: MiR-382 targets GOLM1 to inhibit
metastasis of hepatocellular carcinoma and its down-regulation
predicts a poor survival. Am J Cancer Res. 8:120–131.
2018.PubMed/NCBI
|
|
10
|
Kang W, Huang T, Zhou Y, Zhang J, Lung
RWM, Tong JHM, Chan AWH, Zhang B, Wong CC, Wu F, et al: miR-375 is
involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in
gastric carcinogenesis. Cell Death Dis. 9:922018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wilmott JS, Zhang XD, Hersey P and Scolyer
RA: The emerging important role of microRNAs in the pathogenesis,
diagnosis and treatment of human cancers. Pathology. 43:657–671.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kashyap D, Tuli HS, Garg VK, Goel N and
Bishayee A: Oncogenic and tumor-suppressive roles of MicroRNAs with
special reference to apoptosis: Molecular mechanisms and
therapeutic potential. Mol Diagn Ther. 22:179–201. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Poudyal D, Herman A, Adelsberger JW, Yang
J, Hu X, Chen Q, Bosche M, Sherman BT and Imamichi T: A novel
microRNA, hsa-miR-6852 differentially regulated by Interleukin-27
induces necrosis in cervical cancer cells by downregulating the
FoxM1 expression. Sci Rep. 8:9002018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yasui W, Oue N, Aung PP, Matsumura S,
Shutoh M and Nakayama H: Molecular-pathological prognostic factors
of gastric cancer: A review. Gastric Cancer. 8:86–94. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Carcas LP: Gastric cancer review. J
Carcinog. 13:142014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shimagaki T, Yoshizumi T, Harimoto N,
Yoshio S, Naito Y, Yamamoto Y, Ochiya T, Yoshida Y, Kanto T and
Maehara Y: MicroRNA-125b expression and intrahepatic metastasis are
predictors for early recurrence after hepatocellular carcinoma
resection. Hepatol Res. 48:313–321. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hu X, Wang Y, Liang H, Fan Q, Zhu R, Cui
J, Zhang W, Zen K, Zhang CY, Hou D, et al: miR-23a/b promote tumor
growth and suppress apoptosis by targeting PDCD4 in gastric cancer.
Cell Death Dis. 8:e30592017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao N, Lin T, Zhao C, Zhao S, Zhou S and
Li Y: MicroRNA-588 is upregulated in human prostate cancer with
prognostic and functional implications. J Cell Biochem. Oct
5–2017.(Epub ahead of print). View Article : Google Scholar
|
|
20
|
Shivapurkar N, Vietsch EE, Carney E,
Isaacs C and Wellstein A: Circulating microRNAs in patients with
hormone receptor-positive, metastatic breast cancer treated with
dovitinib. Clin Transl Med. 6:372017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lu C, Xie Z and Peng Q: MiRNA-107 enhances
chemosensitivity to paclitaxel by targeting antiapoptotic factor
Bcl-w in non small cell lung cancer. Am J Cancer Res. 7:1863–1873.
2017.PubMed/NCBI
|
|
22
|
Egan SM, Karasik E, Ellis L and Gollnick
SO: miR-30e* is overexpressed in prostate cancer and promotes
NF-κB-mediated proliferation and tumor growth. Oncotarget.
8:67626–67638. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li J, Wu QM, Wang XQ and Zhang CQ: Long
noncoding RNA miR210HG sponges miR-503 to facilitate osteosarcoma
cell invasion and metastasis. DNA Cell Biol. 36:1117–1125. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zheng Y, Lu X, Xu L, Chen Z, Li Q and Yuan
J: MicroRNA-675 promotes glioma cell proliferation and motility by
negatively regulating retinoblastoma 1. Hum Pathol. 69:63–71. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang X, Liu B, Wen F and Song Y:
MicroRNA-454 inhibits the malignant biological behaviours of
gastric cancer cells by directly targeting mitogen-activated
protein kinase 1. Oncol Rep. 39:1494–1504. 2018.PubMed/NCBI
|
|
26
|
Ding D, Zhang Y, Wen L, Fu J, Bai X, Fan
Y, Lin Y, Dai H, Li Q, Zhang Y and An R: MiR-367 regulates cell
proliferation and metastasis by targeting metastasis-associated
protein 3 (MTA3) in clear-cell renal cell carcinoma. Oncotarget.
8:63084–63095. 2017.PubMed/NCBI
|
|
27
|
He X, Ping J and Wen D: MicroRNA-186
regulates the invasion and metastasis of bladder cancer via
vascular endothelial growth factor C. Exp Ther Med. 14:3253–3258.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Overdier DG, Ye H, Peterson RS, Clevidence
DE and Costa RH: The winged helix transcriptional activator HFH-3
is expressed in the distal tubules of embryonic and adult mouse
kidney. J Biol Chem. 272:13725–13730. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Abedalthagafi MS, Wu MP, Merrill PH, Du Z,
Woo T, Sheu SH, Hurwitz S, Ligon KL and Santagata S: Decreased
FOXJ1 expression and its ciliogenesis programme in aggressive
ependymoma and choroid plexus tumours. J Pathol. 238:584–597. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xian S, Shang D, Kong G and Tian Y: FOXJ1
promotes bladder cancer cell growth and regulates Warburg effect.
Biochem Biophys Res Commun. 495:988–994. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lan Y, Hu X, Jiang K, Yuan W, Zheng F and
Chen H: Significance of the detection of TIM-3 and FOXJ1 in
prostate cancer. J BUON. 22:1017–1021. 2017.PubMed/NCBI
|
|
32
|
Liu K, Fan J and Wu J: Forkhead box
protein J1 (FOXJ1) is overexpressed in colorectal cancer and
promotes nuclear translocation of β-catenin in SW620 cells. Med Sci
Monit. 23:856–866. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang J, Cai X, Xia L, Zhou J, Xin J, Liu
M, Shang X, Liu J, Li X, Chen Z, et al: Decreased expression of
FOXJ1 is a potential prognostic predictor for progression and poor
survival of gastric cancer. Ann Surg Oncol. 22:685–692. 2015.
View Article : Google Scholar : PubMed/NCBI
|
